Stock Fundamentals

Company Information

Company Name
Adicet Bio Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US0070021086
CIK: 0001720580
CUSIP: 004446100
Currency: USD
Full Time Employees: 102
Phone: 650 503 9095
Fiscal Year End: December
IPO Date: Jan 26, 2018
Description:

Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. The company's lead product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR that targets CD20 for the potential treatment of autoimmune diseases. It also develops ADI-212, a gene-edited and armored clinical candidate that targets prostate-specific membrane antigen. The company was founded in 2014 and is based in Boston, Massachusetts.

Address:

131 Dartmouth Street, Boston, MA, United States, 02116

Directors & Officers

Name Title Year Born
Mr. Chen Schor BA, CPA, M.B.A. CEO, President & Director 1972
Dr. Blake Aftab Ph.D. Senior VP & Chief Scientific Officer 1981
Dr. Julie Maltzman M.D. Chief Medical Officer 1968
Mr. Brian Nicholas Harvey M.B.A. Chief Financial Officer 1961
Dr. Donald Healey Ph.D. Chief Technology Officer 1962
Ms. Amy Locke Chief Human Resource Officer NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Feb 20, 2026 Ra Capital Management, L.P. N/A Purchase 74.75K $7.27 $543.44K
Feb 19, 2026 Ra Capital Management, L.P. N/A Purchase 74.27K $7.21 $535.47K
Feb 18, 2026 Ra Capital Management, L.P. N/A Purchase 74.58K $7.04 $525.02K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
RA Capital Management, LLC 1.18M Mar 31, 2026 12.65% $0.09 24.72%
Orbimed Advisors, LLC 1.03M Mar 31, 2026 11.00% $0.14 0.00%
Franklin Resources Inc 626.57K Mar 31, 2026 6.70% $0.00 0.00%
Citadel Advisors Llc 381.82K Mar 31, 2026 4.08% $0.00 254.15%
Vanguard Capital Management, LLC 336.52K Mar 31, 2026 3.60% $0.00 0.00%
Woodline Partners LP 313.12K Mar 31, 2026 3.35% $0.01 -49.90%
Vanguard Group Inc 291.28K Dec 31, 2025 3.12% $0.00 42.41%
Adage Capital Partners Gp LLC 274.38K Mar 31, 2026 2.94% $0.00 0.00%
Prosight Management, LP 250.24K Mar 31, 2026 2.68% $0.28 0.00%
Renaissance Technologies Corp 232.59K Mar 31, 2026 2.49% $0.00 -4.26%
Stonepine Capital Management Llc 221.96K Mar 31, 2026 2.37% $0.61 0.88%
Alyeska Investment Group, L.P. 203.80K Mar 31, 2026 2.18% $0.00 0.00%
The Carlyle Group Inc 184.30K Mar 31, 2026 1.97% $0.01 0.00%
NEXTBio Capital Management LP 157.83K Mar 31, 2026 1.69% $0.50 0.00%
Acadian Asset Management LLC 118.14K Mar 31, 2026 1.26% $0.00 0.00%
Two Sigma Advisers, LLC 111.34K Dec 31, 2025 1.19% $0.00 128.10%
Geode Capital Management, LLC 101.14K Mar 31, 2026 1.08% $0.00 13.82%
Dafna Capital Management LLC 93.81K Mar 31, 2026 1.00% $0.15 0.00%
Burkehill Global Management, LP 62.50K Mar 31, 2026 0.67% $0.02 0.00%
Regeneron Pharmaceuticals Inc 60.51K Dec 31, 2025 0.65% $1.51 0.00%

Shares Statistics

Shares Outstanding: 9.35M
Shares Float: 7.43M
% Insiders: 107.90%
% Institutions: 6,332.90%
Short % Float: 5.43%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Franklin Biotechnology Discv A(acc)USD 401.35K 4.29% ▲ 0.00% Apr 30, 2026
2 Franklin Biotechnology Discovery A 225.19K 2.41% ▲ 0.00% Apr 30, 2026
3 Vanguard Total Stock Mkt Idx Inv 213.12K 2.28% ▲ 0.00% Apr 30, 2026
4 Vanguard Institutional Extnd Mkt Idx Tr 99.25K 1.06% ▲ 0.00% Apr 30, 2026
5 Fidelity Extended Market Index 47.76K 0.51% ▼ 0.36% Apr 30, 2026
6 A4Investments SICAV SIF ACCI IlanaA2EURH 20.00K 0.21% ▲ 0.00% May 31, 2026
7 Vanguard Instl Ttl Stk Mkt Idx InstlPls 18.11K 0.19% ▲ 0.00% Apr 30, 2026
8 Fidelity Total Market Index 17.36K 0.19% ▲ 0.00% Apr 30, 2026
9 Blackstone Alternative Multi-Strategy I 13.74K 0.01% ▲ 22.24% Sep 30, 2025
10 Fidelity Series Total Market Index 12.36K 0.13% ▲ 0.00% Apr 30, 2026

Valuation Metrics

Enterprise Value: $-39.84M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $82.54M
EBITDA: $-107.76M
PEG Ratio: $0.82
Book Value: $13.03
Earnings/Share: $-13.87
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -39.44%
ROE (TTM): -72.19%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -100.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 7.47x 0.02x 0.17x -3,392.06x -0.03x
2024-12-31 9.29x 0.02x 0.15x -31,903.75x -0.03x
2023-12-31 8.41x 0.02x 0.18x -6,081.52x -0.02x
2022-12-31 13.25x 0.01x 0.12x -906.89x -0.04x
2021-12-31 17.31x 0.01x 0.11x -349.05x -0.03x
2020-12-31 4.46x 0.01x 0.29x -292.47x -0.03x
2019-12-31 4.32x 0.00x 1.74x N/A 0.00x
2018-12-31 19.16x 0.00x 0.05x N/A 0.00x
2017-12-31 9.86x 0.29x 0.10x -2.70x -0.43x
2016-12-31 3.57x 0.00x 0.44x 0.00x -197.00x
2015-12-31 2.48x 0.04x 0.48x 21.08x 0.19x
2014-12-31 2.33x 0.04x 0.50x 16.22x 0.19x
2013-12-31 2.43x 0.06x 0.40x 16.22x 0.27x
2012-12-31 2.61x 0.04x 0.44x 9.66x 0.20x
2011-12-31 2.39x 0.00x 0.51x 10.54x 0.00x
2010-12-31 2.62x 0.00x 0.43x 41.03x 0.00x
2009-12-31 3.66x 0.00x 0.34x 121.36x 0.00x
2008-12-31 2.98x 0.00x 0.40x 147.43x 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about ACET.US!